The Axonis federated AI platform

AI can make decisions faster than ever. But if you can’t prove why they were made, you could be left unable to defend them when regulators, auditors or customers come asking. Discover five warning signs your AI architecture is creating decision debt and what to do before it compounds.

AI is moving fast, and one of the best ways to navigate what’s next is to learn from the people actually working through the challenges. In our latest blog, we share key lessons from our Axonis Edge AI Ambassadors on moving AI from ambition to production.

Building trusted, reproducible decisions across data you can't centralize

As AI transforms the economics of information, the real value lies in recognizing patterns across all data sources to uncover insights that would otherwise remain hidden...even when that data spans organizational boundaries, crosses borders and jurisdictions, or resides at the edge.

Enterprise AI has long assumed that better decisions require centralized data. As operational AI emerges, federated architectures are proving a better path, bringing intelligence to distributed data for faster, contextual, and trusted decisions.

AI is creating a new Data Gravity challenge and its a 3 body problem: data increasingly resists centralization, decisions require distributed context, and the cost of moving information keeps rising.

Seth Earley and Axonis CEO Todd Barr explore a fundamental question facing enterprise AI: does data really need to be centralized before it can create value?

Enterprise adoption of artificial intelligence has moved rapidly from experimentation to operational deployment. Organizations now rely on AI systems to support decisions across finance, healthcare, supply chains, and customer operations. These systems increasingly function as analytical collaborators that help professionals interpret large volumes of data and surface relevant insights.

We brought together Vince Albanese (CEO, EKKO | Board Member, DirectTrust) and Axonis CCO Sheth Sanket to talk about what’s changing and what’s at risk as AI moves into real-world clinical and operational decisions.